01 Jan 2019
Little Green Pharma is pleased to announce the company has been granted an Export Licence by the Federal Department of Health, effective 15 January 2019. Obtaining this license meets one of Little Green Pharma’s key strategic milestones on the path to become a key domestic and international supplier of medical cannabis products.
Managing Director, Fleta Solomon believes the strict growing and manufacturing conditions applicable to local suppliers will ultimately give Australian medical cannabis the edge over international competitors, many of which are subject to less stringent quality and manufacturing standards.
Little Green Pharma’s goal is to make clean and natural, Australian-grown and medical grade medical cannabis products to supply both the Australian and overseas markets in 2019.
Company news
Oct 2020
Insights
Mar 2021
Insights
An Australian first. Read more on our export of medicinal cannabis for UK patients.
Apr 2020